Results 81 to 90 of about 15,844 (160)

Genomic insights into head and neck cancer [PDF]

, 2016

core   +1 more source

Lack of interaction between ErbB2 and insulin receptor substrate signaling in breast cancer [PDF]

, 2016

core   +1 more source

Analysis of the molecular mechanism underlying di(2-ethylhexyl) phthalate-induced bladder carcinogenesis via network toxicology and molecular docking approaches: An observational study. [PDF]

Medicine (Baltimore)
Jiang M, Sun C, Wang B, Huang Q, Hu Q, Che X.   +5 more
europepmc   +1 more source

ERBB2 I655V mutation correlates with efficacy of immunotherapy in gallbladder cancer. [PDF]

World J Surg Oncol
Gao Q, You YN, Lian S, Pan C, Zhang ZL, Li KS.   +5 more
europepmc   +1 more source

Expression von Oberflächenrezeptoren beim Bronchialkarziom [PDF]

, 1999
PD Dr. Schuermann, Wimmel, Anja
core   +1 more source

Targeted therapy in the treatment of lung cancer in Iceland 2010-2023. [PDF]

Acta Oncol
Tryggvadóttir SÁ, Stefánsson GV, Birgisson H, Gunnarsson Ö, Guðbjartsson T, Harðardóttir H, Hilmarsdóttir B, Barkardóttir RB, Haraldsdottir S.   +8 more
europepmc   +1 more source

Nerve growth factor (NGF) [PDF]

, 1989
Azzi, Angelo, Borasio, Gian Domenico, Drahota, S., Heumann, R., Lindholm, D., Papa, S., Thoenen, Hans   +6 more
core  

Protein tyrosine kinase 6 (PTK6; BRK); epidermal growth factor receptor (EGFR; ERBB1; HER1); v-erb-b2 erythroblastic leukemia viral oncogene homolog 2 (ERBB2; HER2; Neu) [PDF]

Science-Business eXchange, 2008
openaire   +1 more source

Complete response following trastuzumab-deruxtecan in a man with HER2-overexpressing metastatic, poorly differentiated scrotal carcinoma. [PDF]

Oncologist
Hofstad M, Zheng J, Tachibana I, Zhang T.   +3 more
europepmc   +1 more source

A stage IV high-grade serous ovarian cancer patient carrying ERBB2 amplification and ERBB2 overexpression benefits from late-line pyrotinib treatment: A case report. [PDF]

Sci Prog
Zhu B, Liu Y, Li J, Yang W.
europepmc   +1 more source